Friday, Aug 21, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Business | Dr Reddys Q4 Profit Dips 28 To Rs 557 Cr

Dr Reddy’s Q4 profit dips 28% to Rs 557 cr

For FY21, the company posted a consolidated net profit of Rs 1,952 crore as against Rs 2,026 crore in 2019-20.

By Telangana Today
Published Date - 14 May 2021, 07:24 PM
Dr Reddy’s Q4 profit dips 28% to Rs 557 cr
whatsapp facebook twitter telegram

Hyderabad: Dr Reddy’s Laboratories reported 28 per cent decline in consolidated net profit at Rs 557 crore for the fourth quarter ended March 31, 2021, as against a net profit of Rs 781 crore in January-March quarter of 2019-20.

The company’s net sales however rose to Rs 4,608 crore in the quarter under review as compared with Rs 4,336.1 crore in the fourth quarter of 2019-20, Dr Reddy’s Laboratories said.


For FY21, the company posted a consolidated net profit of Rs 1,952 crore as against Rs 2,026 crore in 2019-20. Net sales increased to Rs 18,420 crore during the last fiscal year as compared with Rs 16,357 crore in 2019-20.

“In FY 21, we continued to grow across all our businesses, enhance productivity and strengthen our development pipeline,” Dr Reddy’s Laboratories co-chairman and MD, G V Prasad said.

The company is prioritising its efforts to launch Sputnik V vaccine across India while working on the development and commercialisation of several drugs for the treatment of mild to severe Covid-19 infections, he added.

The company said it has commenced a detailed investigation into an anonymous complaint which alleges that healthcare professionals in Ukraine and potentially in other countries were provided with improper payments by or on behalf of the company in violation of US anti-corruption laws.

A legal firm is conducting the investigation at the instruction of a committee of the company’s board, it added. Dr Reddy’s noted that it has disclosed the matter to the US Department of Justice, Securities and Exchange Commission and Securities Exchange Board of India.

“While the matter may result in government enforcement actions against the company in the United States and/or foreign jurisdictions, which could lead to civil and criminal sanctions under relevant laws, the probability of such action and the outcome are not reasonably ascertainable at this time,” the company added.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


  • Follow Us :
  • Tags
  • Dr Reddy’s Laboratories
  • Dr.Reddy's

Related News

  • Dr Reddy’s Q1 profit tumbles on semaglutide supply woes

    Dr Reddy’s Q1 profit tumbles on semaglutide supply woes

  • Dr Reddy’s launches oral semaglutide biosimilar Obeda in India

    Dr Reddy’s launches oral semaglutide biosimilar Obeda in India

  • Dr Reddy’s Q4 profit falls 86 per cent on weak North America sales

    Dr Reddy’s Q4 profit falls 86 per cent on weak North America sales

  • Dr Reddy’s Q3 profit dips 14 pc on weak US sales

    Dr Reddy’s Q3 profit dips 14 pc on weak US sales

Latest News

  • NTA defends Rs 200 answer key challenge fee, says it benefits all candidates

    2 hours ago
  • Magnitude 6.7 earthquake strikes southern Peru; no damage reported

    2 hours ago
  • Iran accuses US of ‘economic war’ as Trump threatens tougher sanctions

    3 hours ago
  • Opinion: Section 22-A and Right to Property

    4 hours ago
  • Houthis claim drone attacks on Saudi airport, Aramco facility

    3 hours ago
  • Editorial: Trump’s tariff tantrums fail to dent India’s exports

    4 hours ago
  • India U-20 held to 0-0 draw by Yemen in friendly

    4 hours ago
  • East Bengal women smash 12-0 record win in AFC Women’s Champions League

    4 hours ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam